Advertisement

Topics

TherapeuticsMD updates on regulatory progress of vaginal pain candidate

07:20 EDT 11 Aug 2017 | thePharmaLetter

TherapeuticsMD saw its shares dip 1.23% to $5.60 in after-hours trading on Thursday after it announced…

Original Article: TherapeuticsMD updates on regulatory progress of vaginal pain candidate

NEXT ARTICLE

More From BioPortfolio on "TherapeuticsMD updates on regulatory progress of vaginal pain candidate"

Quick Search
Advertisement